4//SEC Filing
Aegerion Pharmaceuticals, Inc. 4
Accession 0001104659-16-159825
CIK 0001338042operating
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 7:49 PM ET
Size
6.2 KB
Accession
0001104659-16-159825
Insider Transaction Report
Form 4
Stern Donald K
Director
Transactions
- Disposition to Issuer
Stock Option (Right to Buy)
2016-11-29−31,182→ 0 totalExercise: $17.68Exp: 2025-09-17→ Common Stock (31,182 underlying)
Footnotes (2)
- [F1]One-third of the shares of common stock underlying this stock option award vested on September 17, 2016. The remaining two-thirds of the shares of common stock underlying this option were to vest in equal installments on September 17, 2017 and September 17, 2018.
- [F2]Pursuant to the Agreement and Plan of Merger, dated as of June 14, 2016, by and among the Issuer, QLT Inc. ("QLT") and Isotope Acquisition Corp. ("Isotope"), pursuant to which Isotope was merged with and into the Issuer, effective on November 29, 2016, each option to acquire common stock of the Issuer that was outstanding and unexercised immediately prior to the effective time of the merger that had an exercise price per share equal to or greater than $1.88 (the product obtained by multiplying (i) the exchange ratio of 1.0256 by (ii) $1.83, the closing price of a common share of QLT on November 28, 2016) was cancelled without any payment or other consideration therefor.
Documents
Issuer
Aegerion Pharmaceuticals, Inc.
CIK 0001338042
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001338042
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 7:49 PM ET
- Size
- 6.2 KB